MA30413B1 - Nouvelles compositions pharmaceutiques faiblement dosees contenant du nimesulide, leur preparation et utilisation - Google Patents
Nouvelles compositions pharmaceutiques faiblement dosees contenant du nimesulide, leur preparation et utilisationInfo
- Publication number
- MA30413B1 MA30413B1 MA31384A MA31384A MA30413B1 MA 30413 B1 MA30413 B1 MA 30413B1 MA 31384 A MA31384 A MA 31384A MA 31384 A MA31384 A MA 31384A MA 30413 B1 MA30413 B1 MA 30413B1
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- low dose
- nimesulide
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
L'invention concerne une forme pharmaceutique faiblement dosée contenant du nimésulide ou ses sels acceptables pharmaceutiquement, esters, solvates ou hydrates, ainsi que des excipients acceptables pharmaceutiquement. Cette invention a aussi trait à un procédé de préparation de ces formes pharmaceutiques et à leurs méthodes thérapeutiques d'utilisation. Les compositions faiblement dosées (10) sont élaborées pour présenter une certaine biodisponibilité qui est efficace dans le traitement de troubles soignés par des AINS, notamment des troubles qui nécessitent des régimes de traitement à long terme, comme l'arthrite. Ces compositions permettent de diminuer le coût thérapeutique des maladies impliquant des thérapies à long terme, elles sont faciles à produire et débouchent sur la diminution des effets secondaires associés au dosage dans le cadre d'une thérapie au nimésulide.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1033DE2006 | 2006-04-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA30413B1 true MA30413B1 (fr) | 2009-05-04 |
Family
ID=38624596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA31384A MA30413B1 (fr) | 2006-04-24 | 2008-11-14 | Nouvelles compositions pharmaceutiques faiblement dosees contenant du nimesulide, leur preparation et utilisation |
Country Status (14)
Country | Link |
---|---|
US (1) | US20090258947A1 (fr) |
EP (1) | EP2015740A4 (fr) |
JP (1) | JP2009534462A (fr) |
KR (1) | KR20090007608A (fr) |
CN (1) | CN101431992A (fr) |
AU (1) | AU2007242405A1 (fr) |
BR (1) | BRPI0710916A2 (fr) |
CA (1) | CA2649620A1 (fr) |
CR (1) | CR10454A (fr) |
EA (1) | EA200870469A1 (fr) |
MA (1) | MA30413B1 (fr) |
MX (1) | MX2008013605A (fr) |
RS (1) | RS20080497A (fr) |
WO (1) | WO2007122637A1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013108263A1 (fr) | 2012-01-18 | 2013-07-25 | Zota Health Care Ltd | Formulation pharmaceutique destinée à réduire l'inflammation des os et le frottement articulaire avec une qualité de cartilage améliorée |
PL2965759T3 (pl) | 2012-02-06 | 2020-05-18 | Innovative Med Concepts, LLC | Terapia skojarzona związkiem przeciwwirusowym i inhibitorem cox-2 dla fibromialgii |
WO2015023675A2 (fr) | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Comprimé extrudé anti-abus à libération immédiate |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
WO2015095391A1 (fr) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Comprimé extrudé anti-abus à libération prolongée |
CA2955229C (fr) | 2014-07-17 | 2020-03-10 | Pharmaceutical Manufacturing Research Services, Inc. | Forme posologique remplie de liquide anti-abus a liberation immediate |
CN105435239B (zh) * | 2014-08-29 | 2019-04-26 | 武汉光谷人福生物医药有限公司 | 美索舒利薄膜衣片及其制备方法 |
CN105434388B (zh) * | 2014-08-29 | 2018-06-19 | 武汉光谷人福生物医药有限公司 | 美索舒利薄膜衣片 |
CN105434377B (zh) * | 2014-08-29 | 2018-07-03 | 武汉光谷人福生物医药有限公司 | 美索舒利片剂及其制备方法 |
US20160106737A1 (en) | 2014-10-20 | 2016-04-21 | Pharmaceutical Manufacturing Research Services, Inc. | Extended Release Abuse Deterrent Liquid Fill Dosage Form |
RU2593777C1 (ru) * | 2015-04-20 | 2016-08-10 | Общество с ограниченной ответственностью "Трейдсервис" | Гелевая форма нимесулида, обладающая противовоспалительным и анальгетическим действием |
CN108653225B (zh) * | 2018-08-15 | 2021-01-08 | 湖北舒邦药业有限公司 | 一种尼美舒利制剂及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2023552A6 (es) * | 1990-05-22 | 1992-01-16 | Leetrim Limited | Procedimiento para la preparacion de compuestos de inclusion de nimesulida con ciclodextrina. |
HUP9601442A3 (en) * | 1995-07-25 | 1999-03-29 | Panacea Biotec Ltd | Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them |
IN186315B (fr) * | 1996-12-12 | 2001-08-04 | Panacea Biotec Ltd | |
ATE252892T1 (de) * | 1997-09-11 | 2003-11-15 | Nycomed Danmark Aps | Aus mehreren einzeleinheiten zusammengesetzte arzneimittel mit nicht-steroidalen wirkstoffen (nsaids) |
JPH1192355A (ja) * | 1997-09-17 | 1999-04-06 | Shiseido Co Ltd | 皮膚外用剤 |
IN190018B (fr) * | 1999-09-28 | 2003-05-31 | Panacea Biotec Ltd | |
BR0014383A (pt) * | 1999-09-28 | 2002-10-22 | Panacea Biotec Ltd | Composições de liberação controlada compreendendo nimesulida |
BR0113625A (pt) * | 2000-09-08 | 2003-07-22 | Pharmacia Italia Spa | Exemestano como agente de quimioprevenção |
AU2003237988A1 (en) * | 2002-06-13 | 2003-12-31 | Mount Sinai School Of Medicine Of New York University | Inhibiting progressive cognitive impairment |
UA89684C2 (ru) * | 2005-07-20 | 2010-02-25 | Панасеа Биотек Лтд. | Двухслойная фармацевтическая дозированная форма с модифицированным высвобождением нимесулида |
-
2007
- 2007-04-23 EP EP07736597A patent/EP2015740A4/fr not_active Withdrawn
- 2007-04-23 MX MX2008013605A patent/MX2008013605A/es unknown
- 2007-04-23 RS RSP-2008/0497A patent/RS20080497A/sr unknown
- 2007-04-23 KR KR1020087028726A patent/KR20090007608A/ko not_active Application Discontinuation
- 2007-04-23 AU AU2007242405A patent/AU2007242405A1/en not_active Abandoned
- 2007-04-23 JP JP2009507243A patent/JP2009534462A/ja not_active Withdrawn
- 2007-04-23 CA CA002649620A patent/CA2649620A1/fr not_active Abandoned
- 2007-04-23 CN CNA2007800148365A patent/CN101431992A/zh active Pending
- 2007-04-23 EA EA200870469A patent/EA200870469A1/ru unknown
- 2007-04-23 BR BRPI0710916-4A patent/BRPI0710916A2/pt not_active IP Right Cessation
- 2007-04-23 US US12/298,054 patent/US20090258947A1/en not_active Abandoned
- 2007-04-23 WO PCT/IN2007/000162 patent/WO2007122637A1/fr active Application Filing
-
2008
- 2008-11-14 MA MA31384A patent/MA30413B1/fr unknown
- 2008-11-24 CR CR10454A patent/CR10454A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2007242405A1 (en) | 2007-11-01 |
EA200870469A1 (ru) | 2009-04-28 |
BRPI0710916A2 (pt) | 2011-08-23 |
CN101431992A (zh) | 2009-05-13 |
WO2007122637A1 (fr) | 2007-11-01 |
MX2008013605A (es) | 2008-10-30 |
US20090258947A1 (en) | 2009-10-15 |
JP2009534462A (ja) | 2009-09-24 |
CA2649620A1 (fr) | 2007-11-01 |
KR20090007608A (ko) | 2009-01-19 |
EP2015740A4 (fr) | 2009-11-11 |
RS20080497A (en) | 2009-05-06 |
EP2015740A1 (fr) | 2009-01-21 |
CR10454A (es) | 2009-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA30413B1 (fr) | Nouvelles compositions pharmaceutiques faiblement dosees contenant du nimesulide, leur preparation et utilisation | |
MA33467B1 (fr) | Promédicaments comprenant un conjugué insuline-lieur | |
BR112012018500A2 (pt) | alguns inibidores de quinurenina-3-monooxigenase, composições farmacêuticas e métodos de uso destas | |
EP2331095A4 (fr) | Certains inhibiteurs de kynurénine-3-monooxygénase, compositions pharmaceutiques, et procédés d'utilisation de ceux-ci | |
EA200100872A1 (ru) | Композиция валдекоксиба | |
EA201490163A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
MA33295B1 (fr) | Nouvelle formulation de diclofénac | |
MA35455B1 (fr) | (wo2013045407) dérivés d'estra-1,3,5(10),16-tétraène-3-carboxamide, procédé pour leur fabrication, préparations pharmaceutiques contenant ces substances ainsi que leur utilisation dans la fabrication de médicaments | |
MA34083B1 (fr) | Compositions pharmaceutques de composé spiro-oxindole pour administration topique et leur utilisation en tant qu'agents thérapeutiques | |
EA201490277A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
EA200802020A1 (ru) | Тетрагидропиримидоазепины и их применение в качестве модуляторов trpv 1 | |
ATE543491T1 (de) | Kombinationspräparat enthaltend ibuprofen und paracetamol | |
MA37610B1 (fr) | Formulations de testostérone proliposomales | |
MA29366B1 (fr) | Therapie antiangiogenique de maladie auto-immune chez des patients qui n'ont pas reagi a une therapie anterieure | |
MA33533B1 (fr) | Compositions pharmaceutiques pour le traitement du cancer et d'autres maladies ou troubles | |
RU2007104774A (ru) | Комбинация анти-вич ингибиторов обратной транскриптазы и протеазы | |
MA37763B1 (fr) | Difluoro-hexahydro-cyclopentaoxazinyles et difluoro-hexahydro-benzooxazinyles en tant qu'inhibiteurs de bace1 | |
AR044775A1 (es) | Composiciones farmaceuticas de atorvastatina | |
MA30779B1 (fr) | Comprimes pediatriques de capecitabine | |
BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
MA37691B1 (fr) | 5-amino[1,4]thiazines comme inhibiteurs de bace1 | |
MA57226B1 (fr) | Méthodes de traitement d'une splénomégalie | |
JP2006516571A5 (fr) | ||
EA202190544A1 (ru) | Применение распадающихся в полости рта таблеток рилузола для лечения заболеваний | |
AR046036A1 (es) | Composiciones de risedronato y metodos para su uso |